US Market Report for Dental Soft Tissue Regeneration 2017 – MedCore

US Market Report for Dental Soft Tissue Regeneration 2017 – MedCore


Dental soft tissue regeneration devices are used to facilitate the regeneration of soft tissue, either in response to soft tissue recession or during a dental implant procedure. Applications for the devices include soft tissue augmentation around dental implants, root coverage, gingival augmentation and soft tissue ridge augmentation. The two main classes of dental soft tissue regeneration products are allografts (human tissue-derived) and xenografts (non-human animal tissue-derived). This market does not include alloplasts, as these products fall into the barrier membrane category.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 528
  • Type: MedCore

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
An important distinction exists between dental soft tissue regeneration products and barrier membrane products. Barrier membranes, also known as dental membranes, are devices that are used during bone grafting procedures that are designed to promote guided bone regeneration (GBR). These devices fall into two main categories: resorbable membranes (including allografts and xenografts) and non-resorbable membranes (alloplasts). The non-resorbable synthetic alloplast membranes must be removed in a separate procedure after the healing process is complete. Non-resorbable membranes were typically manufactured using synthetic materials such as polytetrafluoroethylene (PTFE). This type of membrane stays in place for 3 to 4 weeks, after which it must be removed by dentists. This provides sufficient time for the blood clot to form, graft material to consolidate and osseous tissue to begin forming under the membrane. Resorbable membranes (allografts and xenografts) break down after four to twelve weeks depending on the membrane brand, and are absorbed into the body, eliminating the need for a second procedure. These barrier membrane products essentially function to protect the bone graft as it develops by acting as a barrier, preventing soft tissue from growing into the regenerating bone. Bone is anatomically classified as a mineralized tissue, which differs substantially in function compared to soft tissue. For this reason, barrier membranes will not be included in the analysis of this report. Only devices that are directly involved in facilitating the regeneration and remodeling of soft tissue are included in the analysis.

The "US Market Report Suite for Soft Tissue Reinforcement and Regeneration 2017 - MedSuite" includes analysis on the following companies currently active in this market:
C.R. Bard
Wright Medical
Integra LifeSciences
Smith & Nephew
Boston Scientific
Atrium Medical
Cook Medical
Johnson & Johnson
Soluble Systems
RTI Biologics
Zimmer Biomet
Aesculap/B. Braun
Gore Medical
Others include: Medline, MTF, WL Gore, Tutogen, Novus Scientific, Ariste Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers